Search headlines
Find recent stories from Scroll News feeds, then read or analyze them.
Search across recent items from all feeds.
Active filters: Keyword · All time
Results for " GLP-1 " · 37 found
In earnings call, Hims CEO addresses scrutiny of GLP-1 compounding
😔
Negative
(-40%)
Missed Out on Eli Lilly? 2 Healthcare Stocks With Big Catalysts on the Horizon.
😐
Neutral
(0%)
Why Hims & Hers Health (HIMS) Is Down 6.8% After Amazon Pharmacy Adds Wegovy Weight-Loss Pill
MBX Biosciences to Provide 2026 Outlook and Business Update at 44th Annual J.P. Morgan Healthcare Conference
Noom launches a GLP-1-based, long-term, preventive health care program
😊
Positive
(13%)
The Weight-Loss Drug Revolution—From Shots to Pills and the Science behind It All
😊
Positive
(14%)
2026 Health Care Predictions: AI, GLP-1s, MAHA, DEI: Sachin H. Jain, MD, MBA
😐
Neutral
(0%)
In 2026, Kennedy’s MAHA vision gets put to the test. Here are 3 issues to watch
😐
Neutral
(0%)
These people lost their sense of taste. Are GLP-1s to blame?
😊
Positive
(10%)
GLP-1s may weaken the pelvic floor, impacting women's health –– and their sex lives
😐
Neutral
(3%)
Wave Life Sciences Announces Positive Interim Data from Phase 1 INLIGHT Trial of WVE-007 (INHBE) for Obesity; Single Dose Resulted in Improvement in Body Composition With Fat Loss Similar to GLP-1 at Three Months Without Muscle Loss
Driven by GLP-1s, prescription drug spending explodes at major health insurers
😊
Positive
(7%)
Here’s What the World Health Organization Had to Say About GLP-1s in its First-Ever Guideline on the Drugs
World Health Organization issues guidelines for GLP-1 weight loss medication use
😊
Positive
(16%)
WHO issues guidance on GLP-1 drugs for obesity, calls them a "scientific breakthrough" and "new chapter"
WHO issues global guideline on the use of GLP-1 medicines in treating obesity
😊
Positive
(10%)